132 related articles for article (PubMed ID: 19941167)
1. Heterogeneous prevalence of recurrent BRCA1 and BRCA2 mutations in Spain according to the geographical area: implications for genetic testing.
Diez O; Gutiérrez-Enríquez S; Balmaña J
Fam Cancer; 2010 Jun; 9(2):187-91. PubMed ID: 19941167
[TBL] [Abstract][Full Text] [Related]
2. Genetic analysis of BRCA1 and BRCA2 in breast/ovarian cancer families from Aragon (Spain): two novel truncating mutations and a large genomic deletion in BRCA1.
Miramar MD; Calvo MT; Rodriguez A; Antón A; Lorente F; Barrio E; Herrero A; Burriel J; García de Jalón A
Breast Cancer Res Treat; 2008 Nov; 112(2):353-8. PubMed ID: 18176857
[TBL] [Abstract][Full Text] [Related]
3. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
4. BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland.
Ikonen T; Matikainen MP; Syrjäkoski K; Mononen N; Koivisto PA; Rökman A; Seppälä EH; Kallioniemi OP; Tammela TL; Schleutker J
J Med Genet; 2003 Aug; 40(8):e98. PubMed ID: 12920090
[No Abstract] [Full Text] [Related]
5. Hereditary breast and ovarian cancer in Andalusian families: a genetic population study.
Pajares B; Porta J; Porta JM; Sousa CF; Moreno I; Porta D; Durán G; Vega T; Ortiz I; Muriel C; Alba E; Márquez A
BMC Cancer; 2018 Jun; 18(1):647. PubMed ID: 29884136
[TBL] [Abstract][Full Text] [Related]
6. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
7. Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: implications for genetic testing.
de la Hoya M; Osorio A; Godino J; Sulleiro S; Tosar A; Perez-Segura P; Fernandez C; Rodríguez R; Díaz-Rubio E; Benítez J; Devilee P; Caldés T
Int J Cancer; 2002 Feb; 97(4):466-71. PubMed ID: 11802208
[TBL] [Abstract][Full Text] [Related]
8. Differences in the frequency and distribution of BRCA1 and BRCA2 mutations in breast/ovarian cancer cases from the Basque country with respect to the Spanish population: implications for genetic counselling.
Beristain E; Martínez-Bouzas C; Guerra I; Viguera N; Moreno J; Ibañez E; Díez J; Rodríguez F; Mallabiabarrena G; Luján S; Gorostiaga J; De Pablo JL; Mendizabal JL; Tejada MI
Breast Cancer Res Treat; 2007 Dec; 106(2):255-62. PubMed ID: 17262179
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.
de Juan I; Palanca S; Domenech A; Feliubadaló L; Segura Á; Osorio A; Chirivella I; de la Hoya M; Sánchez AB; Infante M; Tena I; Díez O; Garcia-Casado Z; Vega A; Teulé À; Barroso A; Pérez P; Durán M; Carrasco E; Juan-Fita MJ; Murria R; Llop M; Barragan E; Izquierdo Á; Benítez J; Caldés T; Salas D; Bolufer P
Fam Cancer; 2015 Dec; 14(4):505-13. PubMed ID: 26026974
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
Rebbeck TR; Friebel TM; Friedman E; Hamann U; Huo D; Kwong A; Olah E; Olopade OI; Solano AR; Teo SH; Thomassen M; Weitzel JN; Chan TL; Couch FJ; Goldgar DE; Kruse TA; Palmero EI; Park SK; Torres D; van Rensburg EJ; McGuffog L; Parsons MT; Leslie G; Aalfs CM; Abugattas J; Adlard J; Agata S; Aittomäki K; Andrews L; Andrulis IL; Arason A; Arnold N; Arun BK; Asseryanis E; Auerbach L; Azzollini J; Balmaña J; Barile M; Barkardottir RB; Barrowdale D; Benitez J; Berger A; Berger R; Blanco AM; Blazer KR; Blok MJ; Bonadona V; Bonanni B; Bradbury AR; Brewer C; Buecher B; Buys SS; Caldes T; Caliebe A; Caligo MA; Campbell I; Caputo SM; Chiquette J; Chung WK; Claes KBM; Collée JM; Cook J; Davidson R; de la Hoya M; De Leeneer K; de Pauw A; Delnatte C; Diez O; Ding YC; Ditsch N; Domchek SM; Dorfling CM; Velazquez C; Dworniczak B; Eason J; Easton DF; Eeles R; Ehrencrona H; Ejlertsen B; ; Engel C; Engert S; Evans DG; Faivre L; Feliubadaló L; Ferrer SF; Foretova L; Fowler J; Frost D; Galvão HCR; Ganz PA; Garber J; Gauthier-Villars M; Gehrig A; ; Gerdes AM; Gesta P; Giannini G; Giraud S; Glendon G; Godwin AK; Greene MH; Gronwald J; Gutierrez-Barrera A; Hahnen E; Hauke J; ; Henderson A; Hentschel J; Hogervorst FBL; Honisch E; Imyanitov EN; Isaacs C; Izatt L; Izquierdo A; Jakubowska A; James P; Janavicius R; Jensen UB; John EM; Vijai J; Kaczmarek K; Karlan BY; Kast K; Investigators K; Kim SW; Konstantopoulou I; Korach J; Laitman Y; Lasa A; Lasset C; Lázaro C; Lee A; Lee MH; Lester J; Lesueur F; Liljegren A; Lindor NM; Longy M; Loud JT; Lu KH; Lubinski J; Machackova E; Manoukian S; Mari V; Martínez-Bouzas C; Matrai Z; Mebirouk N; Meijers-Heijboer HEJ; Meindl A; Mensenkamp AR; Mickys U; Miller A; Montagna M; Moysich KB; Mulligan AM; Musinsky J; Neuhausen SL; Nevanlinna H; Ngeow J; Nguyen HP; Niederacher D; Nielsen HR; Nielsen FC; Nussbaum RL; Offit K; Öfverholm A; Ong KR; Osorio A; Papi L; Papp J; Pasini B; Pedersen IS; Peixoto A; Peruga N; Peterlongo P; Pohl E; Pradhan N; Prajzendanc K; Prieur F; Pujol P; Radice P; Ramus SJ; Rantala J; Rashid MU; Rhiem K; Robson M; Rodriguez GC; Rogers MT; Rudaitis V; Schmidt AY; Schmutzler RK; Senter L; Shah PD; Sharma P; Side LE; Simard J; Singer CF; Skytte AB; Slavin TP; Snape K; Sobol H; Southey M; Steele L; Steinemann D; Sukiennicki G; Sutter C; Szabo CI; Tan YY; Teixeira MR; Terry MB; Teulé A; Thomas A; Thull DL; Tischkowitz M; Tognazzo S; Toland AE; Topka S; Trainer AH; Tung N; van Asperen CJ; van der Hout AH; van der Kolk LE; van der Luijt RB; Van Heetvelde M; Varesco L; Varon-Mateeva R; Vega A; Villarreal-Garza C; von Wachenfeldt A; Walker L; Wang-Gohrke S; Wappenschmidt B; Weber BHF; Yannoukakos D; Yoon SY; Zanzottera C; Zidan J; Zorn KK; Hutten Selkirk CG; Hulick PJ; Chenevix-Trench G; Spurdle AB; Antoniou AC; Nathanson KL
Hum Mutat; 2018 May; 39(5):593-620. PubMed ID: 29446198
[TBL] [Abstract][Full Text] [Related]
11. Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy.
Cini G; Mezzavilla M; Della Puppa L; Cupelli E; Fornasin A; D'Elia AV; Dolcetti R; Damante G; Bertok S; Miolo G; Maestro R; de Paoli P; Amoroso A; Viel A
BMC Med Genet; 2016 Feb; 17():11. PubMed ID: 26852130
[TBL] [Abstract][Full Text] [Related]
12. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
13. Geographical distribution of Slovenian BRCA1/2 families according to family origin: implications for genetic screening.
Krajc M; Zadnik V; Novaković S; Stegel V; Teugels E; Bešič N; Hočevar M; Vakselj A; De Grève J; Zgajnar J
Clin Genet; 2014 Jan; 85(1):59-63. PubMed ID: 23397983
[TBL] [Abstract][Full Text] [Related]
14. Five Italian Families with Two Mutations in
Vietri MT; Caliendo G; D'Elia G; Resse M; Casamassimi A; Minucci PB; Dello Ioio C; Cioffi M; Molinari AM
Genes (Basel); 2020 Dec; 11(12):. PubMed ID: 33287145
[TBL] [Abstract][Full Text] [Related]
15. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.
Riahi A; Chabouni-Bouhamed H; Kharrat M
Cancer Genet; 2017 Jan; 210():22-27. PubMed ID: 28212807
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 and BRCA2 germline testing in Cretan isolates reveals novel and strong founder effects.
Apostolou P; Fostira F; Kouroussis C; Kalfakakou D; Delimitsou A; Agelaki S; Androulakis N; Christodoulou C; Kalbakis K; Kalykaki A; Sanidas E; Papadimitriou C; Vamvakas L; Georgoulias V; Mavroudis D; Yannoukakos D; Konstantopoulou I; Saloustros E
Int J Cancer; 2020 Sep; 147(5):1334-1342. PubMed ID: 32022259
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer.
Simard J; Dumont M; Moisan AM; Gaborieau V; Malouin H; Durocher F; Chiquette J; Plante M; Avard D; Bessette P; Brousseau C; Dorval M; Godard B; Houde L; ; Joly Y; Lajoie MA; Leblanc G; Lépine J; Lespérance B; Vézina H; Parboosingh J; Pichette R; Provencher L; Rhéaume J; Sinnett D; Samson C; Simard JC; Tranchant M; Voyer P; Easton D; Tavtigian SV; Knoppers BM; Laframboise R; Bridge P; Goldgar D
J Med Genet; 2007 Feb; 44(2):107-21. PubMed ID: 16905680
[TBL] [Abstract][Full Text] [Related]
19. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain.
Milne RL; Osorio A; Cajal TR; Vega A; Llort G; de la Hoya M; Díez O; Alonso MC; Lazaro C; Blanco I; Sánchez-de-Abajo A; Caldés T; Blanco A; Graña B; Durán M; Velasco E; Chirivella I; Cardeñosa EE; Tejada MI; Beristain E; Miramar MD; Calvo MT; Martínez E; Guillén C; Salazar R; San Román C; Antoniou AC; Urioste M; Benítez J
Clin Cancer Res; 2008 May; 14(9):2861-9. PubMed ID: 18451254
[TBL] [Abstract][Full Text] [Related]
20. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
